Exhibit 3.1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (date of earliest event reported): April 18, 2022
QHSLab, Inc.
(Exact Name of Registrant as Specified in its Charter)
0-19041
(Commission File No.)
| Nevada | 30-1104301 | |
(State of Incorporation) |
(I.R.S. Employer Identification No.) | |
901 Northpoint Parkway Suite 302 West Palm Beach FL 33407 |
33407 | |
| (Address of Principal Executive Offices) | (ZIP Code) |
Registrant’s telephone number, including area code: (929) 379-6503
USA EQUITIES CORP.
(Former name or former address if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c) |
Securities registered pursuant to Section 12(g) of the Act:
| Title of each class | Trading Symbol(s) |
Name of each exchange on which registered | ||
| Common Stock, $0.0001 par value | USAQ | N/A |
ITEM 5.03 Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On April 18, 2022, the Financial Industry Regulatory Authority approved the change in the Company’s name to QHSLab, Inc. effective April 19, 2022. The name change had been effected by the filing of a Certificate of Amendment to the Company’s Certificate of Incorporation with the Secretary of State of the State of Nevada.
No other changes were made to the Company’s Certificate of Incorporation or the rights of its stockholders by the Certificate of Amendment and the Company’s common stock continues to trade under the symbol “USAQ.” Holders of the Company’s common stock do not need to take any action as a result of the name change.
Item 7.01 Regulation FD Disclosure.
On April 19, 2022 the Company issued a press release announcing the change in its corporate name. The full text of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 7.01 and shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.
The Company uses, and will continue to use, its website, press releases, and various social media channels, including its Twitter account, its LinkedIn account, its Facebook account and its Instagram account as additional means of disclosing public information to investors, the media and others interested in the Company. It is possible that certain information that the Company posts on its website, disseminated in press releases and on social media could be deemed to be material information, and the Company encourages investors, the media and others interested in the Company to review the business and financial information that the Company posts on its website, disseminates in press releases and on the social media channels identified above, as such information could be deemed to be material information.
Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits.
The exhibits listed in the following Exhibit Index are filed as part of this Current Report on Form 8-K.
Exhibit No. |
Description | |
| 3.1 | Certificate of Amendment to Certificate of Incorporation filed with the Secretary of State of Nevada to change the name of the Company | |
| 99.1 | Press Release dated April 19, 2022, USA Equities Corp (USAQ) Announces Name Change to QHSLab, Inc. | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: April 19, 2022 | ||
| QHSLab, Inc. | ||
| /s/ Troy Grogan | ||
| Name: | Troy Grogan | |
| Title: | CEO and Chairman | |
Exhibit 3.1
Exhibit 99.1
USA Equities Corp (USAQ) Announces Name Change to QHSLab, Inc.
The name change comes from the strong brand recognition garnered by the company’s flagship product, QHSLab
WEST PALM BEACH, FL – (April 19, 2022) – USA Equities Corp (USAQ: OTCQB) has announced that the company is now named QHSLab, Inc. after receiving FINRA approval. The name change signals an exciting moment of growth for the company that provides digital health solutions and point of care diagnostic tests to primary care physicians. The company’s flagship product, QHSLab, has garnered brand recognition, and after reviewing strong 2021 earnings, company leadership decided to make QHSLab, Inc. the company’s name.
QHSLab, Inc. is a medical device technology company focused on enabling primary care physicians (PCPs) to increase their revenues by providing, value-based tools to evaluate and treat chronic disease through reimbursable procedures. QHSLab, Inc. will continue to be led by a group of concerned doctors, academics, health professionals, informatics, and information technology professionals. Likewise, the mission remains the same: equipping individuals to take control of their health through physician-directed digital medicine and innovative, AI-enhanced, preventive health technologies that streamline the care process.
“Our name change is a natural step in the growth process for our company and signals the strength of our brand. QHSLab’s brand name and recognition has continued to gain strength since we launched our platform. We are expanding our product portfolio so making the name change from USA Equities Corp. to QHSLab, Inc. was a fairly straightforward decision,” said Troy Grogan, President and CEO of QHSLab, Inc. “We’re thrilled with the progress we made in 2021 and have continued momentum through Q1 launching new digital products to our physician client base this year,” concluded Grogan.
For more information, please visit www.usaqcorp.com.
About QHSLab, Inc.
QHSLab, Inc. (OTCQB: USAQ) is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. Digital healthcare allows doctors to assess their patients’ responses quickly and effectively using advanced artificial intelligence algorithms. Digital healthcare can also remotely monitor patients’ vital signs and evaluate the effects of prescribed medicines and treatments on patients’ health through real-time data transferred from patient to doctor. QHSLab, Inc. also markets and sells point-of-care, rapid-response diagnostic tests used in the primary care practice. QHSLab, Inc.’s products and services are designed to help physicians improve patient monitoring and medical care while also improving the revenues of their practice.
Forward-Looking Statements
Certain matters discussed in this press release are ‘forward-looking statements’ intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company’s statements regarding trends in the marketplace, future revenues, future products, and potential future results and acquisitions are examples of such forward-looking statements. Forward-looking statements are generally identified by words such as ‘may,’ ‘could,’ ‘believes,’ ‘estimates,’ ‘targets,’ ‘expects,’ or ‘intends,’ and other similar words that express risks and uncertainties. These statements are subject to numerous risks and uncertainties, including, but not limited to, the timing of the introduction of new products, the inherent discrepancy in actual results from estimates, projections, and forecasts made by management, regulatory delays, changes in government funding and budgets, and other factors, including general economic conditions, not within the Company’s control. The factors discussed herein and expressed from time to time in the Company’s filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release. The Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
Investor Relations Contact:
Olivia Giamanco
QHSLab, Inc.
(929) 379-6503
ir@usaqcorp.com